Research Article
Simple Bedside Predictors of Survival after Percutaneous Gastrostomy Tube Insertion
Table 1
Demographics and laboratory characteristics of study cohort.
| | Parameters | Group A (short-term mortality) | Group B (long-term survivals) |
| | Number of patients | 64 | 208 | | Age (years) (mean ± SD) | 77.3 ± 14 | 70.4 ± 17 | | Gender, N (%) | | | | Male | 32 (50) | 32 (50) | | Female | 103 (49.5) | 105 (50.5) | | Background diseases, N (%) | | | | Diabetes mellitus | 24 (37.5) | 70 (33.6) | | Ischemic heart disease | 25 (39) | 50 (24) | | Congestive heart failure | 11 (17.2) | 21 (10.1) | | Hypertension | 45 (70.3) | 142 (68.3) | | Stroke | 27 (42.2) | 63 (30.3) | | Indications for PEG, N (%) | | | | Dementia | 35 (54.7) | 86 (41.3) | | Stroke | 28 (43.7) | 77 (37) | | Anoxic brain damage | 9 (14.1) | 31 (14.9) | | Degenerative disease | 2 (3.1) | 10 (4.8) | | Cerebral palsy | 3 (4.7) | 4 (1.9) | | Malignancy (head, neck, and oropharyngeal) | 1 (1.6) | 26 (12.5) | | ALT (unit/L) | 26.9 ± 28 | 35.5 ± 48 | | AST (unit/L) | 36.5 ± 28.2 | 32.6 ± 27 | | ALP (unit/L) | 93 ± 48 | 93.4 ± 49.9 | | Creatinine (mg/dl) | 1.06 ± 1.03 | 0.71 ± 0.38 | | Albumin (g/dl) | 2.65 ± 0.5 | 2.92 ± 0.5 | | Hemoglobin (g/dl) | 9.68 ± 1.94 | 10.55 ± 1.8 | | CRP (mg/L) | 103.7 ± 84.5 | 60.7 ± 61.1 | | CRP-to-albumin ratio | 42.2 ± 39.3 | 22.3 ± 24 |
|
|
